The modern therapy of systemic vasculitides: perspectives and challenges

by P I Novikov, A S Zykova, S V Moiseev
Published 2018-01-01

The modern therapy of systemic vasculitides: perspectives and challenges

by P.I. NOVIKOV, A.S. ZYKOVA, S.V. MOISEEV
Published 2018-01-01

CERTOLIZUMAB PEGOL IN THE TREATMENT OF TAKAYASU ARTERITIS: THE FIRST EXPERIENCE AND PROSPECTS

by P. I. Novikov, I. O. Smitienko, M. V. Sokolova, S. V. Moiseev
Published 2018-07-01

Ophthalmologic manifestations of granulomatosis with polyangiitis (Wegener’s granulomatosis)

by Ya O Grusha, D S Ismailova, P I Novikov, Yu V Abramova
Published 2015-12-01

Clinical features of kidney involvement in microscopic microscopic polyangiitis

by E M Shchegoleva, N M Bulanov, P I Novikov, S V Moiseev
Published 2018-06-01

Systemic lupus erythematosus with the development of neuromyelitis optica (Devic's syndrome) is a rare combination of autoimmune diseases

by E. S. Vinogradova, A. P. Panova, N. M. Bulanov, P. I. Novikov, S. V. Moiseev
Published 2019-10-01

Giant cell arteritis as a cause of fever of unclear genesis in the elderly

by S V Guliaev, A D Meshkov, P I Novikov, S V Moiseev, V V Fomin
Published 2014-12-01

Atherosclerosis in ANCA-associated systemic vasculitides

by E I Kuznetsova, Leonid Aleksandrovich Strizhakov, P I Novikov, S V Moiseyev, V D Shcherbakova
Published 2012-06-01

Giant cell arteritis: Genetic and epigenetic aspects

by S V Guliaev, L A Strizhakov, P I Novikov, N A Mukhin, V V Fomin
Published 2017-08-01

The frequency of ophthalmologic manifestations of granulomatosis with polyangiitis (Wegener’s) and their relationship to systemic diseases

by D S Ismailova, P I Novikov, Ya O Grusha, Yu V Abramova, N M Bulanov, E A Makarov
Published 2017-05-01

Correlation between clinical data and cytokines parameters in patients with Granulomatosis with Poilyangiitis (Wegener Granulomatosis)

by I. A. Lopatina, S. V. Moiseev, P. I. Novikov, L. I. Russu, E. I. Isaeva, M. V. Mezentseva
Published 2017-06-01

Experience with rituximab treatment (monoclonal antibodies to B-lymphocyte CD20 receptors) of Wegener's granulematosis patients with renal impairment

by Pavel Igorevich Novikov, O G Krivosheev, Evgeniya Nikolaevna Semenkova, P I Novikov, O G Krivosheev, E N Semenkova
Published 2011-11-01

Clinicopatological variants and risk factors for chronic kidney disease in rheumatoid arthritis

by N. V. Chebotareva, S. V. Gulyaev, T. V. Androsova, E. N. Popova, D. V. Gurova, P. I. Novikov, L. Yu. Milovanova, S. V. Moiseev
Published 2020-06-01

Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides

by N M Bulanov, E A Makarov, E M Shchegoleva, A S Zykova, E S Vinogradova, P I Novikov, L V Lysenko(Kozlovskaya), S V Moiseev
Published 2018-06-01

Hepatitis C virus-associated cryoglobulinemic vasculitis: A 20-year experience with treatment

by T M Ignatova, L V Kozlovskaya, N B Gordovskaya, O A Chernova, S Yu Milovanova, P I Novikov, T P Nekrasova, T V Beketova, N A Mukhin
Published 2017-05-01

Severe Wegener's granulomatosis successfully treated with rituximab

by E N Semenkova, O G Krivosheyev, P I Novikov, V I Osipenko, N R Nosova, S A Parfenova, N V Nikiforova, O O Borodin
Published 2010-06-01

Liver involvement in patients with systemic lupus erythematosus

by A. P. Panova, V. G. Avdeev, T. N. Krasnova, T. P. Rozina, E. P. Pavlikova, O. A. Georginova, A. L. Filatova, E. N. Borisov, P. I. Novikov
Published 2021-05-01

Поражение сердца при системных васкулитах: патогенетические звенья, значение факторов риска развития сердечно-сосудистых осложнений и диагностика...

by L A Strizhakov, S V Moiseev, E A Kogan, S P Pasha, L Iu Churganova, V E Ditterle, P I Novikov, E N Semenkova, N A Mukhin
Published 2014-12-01

Impact of interleukin-10 and interleukin-28 gene polymorphisms on the development and course of lupus nephritis

by T N Krasnova, L M Samokhodskaya, L V Ivanitsky, A D Korogodina, E N Borisov, N V Nikiforova, P I Novikov, A A Kamalov, N A Mukhin
Published 2015-06-01

Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases

by S V Moiseev, P I Novikov, E N Semenkova, L A Strizhakov, S V Guliaev, T N Ianushkevich, N V Nikiforova, A D Meshkov, V V Panasiuk, Iu D Sorokin, M V Taranova, S A Parfenova, L V Dubrovskaia, E S Zhabina, E I Kuznetsova, I A Lopatina, N M Bulanov, N A Mukhin
Published 2013-05-01